Control of autoimmunity by follicular helper T cells and BCL6
滤泡辅助 T 细胞和 BCL6 控制自身免疫
基本信息
- 批准号:8072744
- 负责人:
- 金额:$ 22.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-15 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody FormationAntigensAutoimmune DiseasesAutoimmunityB-LymphocytesBCL6 geneBLR1 geneCD4 Positive T LymphocytesCell Differentiation processCellsDataDevelopmentDiseaseDisease ProgressionDoseHelper-Inducer T-LymphocyteImmune responseImmunityLeadLinkLupusPathologicPeptidesPharmaceutical PreparationsPhenotypeReactionRoleStructure of germinal center of lymph nodeSystemT-LymphocyteTestingTranscription Repressor/Corepressorchemokine receptorcytokinefightingin vitro activityin vivoinhibitor/antagonistmouse modelnovelpublic health relevanceresearch studyresponsesmall moleculevaccine development
项目摘要
DESCRIPTION (provided by applicant): CD4 T helper cells are critical for the proper orchestration of the immune response and are essential for helping B cells make high affinity antigen-specific antibody. Follicular helper T (Tfh) cells are a recently characterized subset of CD4 T cells whose role is specifically to help B cells produce antibody, in part by promoting the germinal center reaction. However, deregulated development of Tfh cells can lead to autoimmune disease. Tfh cells are localized to B cell follicles and thus express the chemokine receptor CXCR5. Tfh cells are also characterized by high expression of the transcription repressor BCL6, and secretion of the B cell stimulatory cytokine IL-21. Recent data indicates that BCL6 is the master transcriptional regulator for Tfh cells: forced BCL6 expression can induce the Tfh phenotype in T cells, and Tfh cells cannot develop in the absence of BCL6. In this proposal, we seek to take advantage of the central role for BCL6 in Tfh development and function to better understand the link between Tfh cells and auto-immunity. Our hypothesis is that increased Tfh activity promoted by BCL6 can lead to non-specific antibody responses and eventually to autoimmunity, while blockade of BCL6 activity can block Tfh function and thus inhibit autoimmune disease progression. This hypothesis will be tested in the specific aims described below. This study will provide information that is critical for the manipulation of Tfh cells in vaccine development. Further, these experiments may lead to novel treatments for autoimmune diseases such as lupus.
PUBLIC HEALTH RELEVANCE: CD4 T helper cells are critical for the proper orchestration of the immune response, and CD4 T cells are particularly important in helping B cells in make antigen-specific antibody that fights disease. Follicular helper T (Tfh) cells are a recently discovered type of CD4 T cells whose role is specifically to help B cells produce antibody. However, Tfh cells can also promote autoimmune disease. Here we want to probe the relationship between Tfh cells and autoimmunity using a novel system, and also use a novel drug to block Tfh function. These studies may lead to new therapies for the treatment of autoimmune disease.
描述(由申请人提供):CD4 T辅助细胞对于适当的免疫反应编排至关重要,对于帮助B细胞制造高亲和力抗原特异性抗体至关重要。卵泡辅助辅助剂T(TFH)细胞是最近表征的CD4 T细胞子集,其作用专门帮助B细胞产生抗体,部分通过促进生发中心反应。但是,TFH细胞的放松开发会导致自身免疫性疾病。 TFH细胞位于B细胞卵泡中,从而表达趋化因子受体CXCR5。 TFH细胞还以转录阻遏物Bcl6的高表达和B细胞刺激细胞因子IL-21的分泌。最近的数据表明,BCl6是TFH细胞的主要转录调节剂:强迫BCL6表达可以诱导T细胞中的TFH表型,并且在没有BCL6的情况下,TFH细胞无法发展。在此提案中,我们试图利用BCL6在TFH开发和功能中的核心作用,以更好地了解TFH细胞与自动免疫之间的联系。我们的假设是,由BCl6促进的TFH活性增加会导致非特异性抗体反应并最终导致自身免疫性,而BCl6活性的阻断可以阻止TFH功能,从而抑制自身免疫性疾病进展。该假设将在下面描述的具体目的中进行检验。这项研究将提供有关在疫苗开发中操纵TFH细胞至关重要的信息。此外,这些实验可能导致对狼疮等自身免疫性疾病的新型治疗方法。
公共卫生相关性:CD4 T辅助细胞对于适当的免疫反应编排至关重要,CD4 T细胞在帮助B细胞制造抗原特异性抗体中尤其重要。卵泡辅助辅助剂T(TFH)细胞是最近发现的CD4 T细胞的类型,其作用专门帮助B细胞产生抗体。但是,TFH细胞也可以促进自身免疫性疾病。在这里,我们想使用新型系统探测TFH细胞与自身免疫性之间的关系,并使用新型药物来阻止TFH功能。这些研究可能会导致新疗法用于治疗自身免疫性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander L Dent其他文献
Alexander L Dent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander L Dent', 18)}}的其他基金
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 22.87万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 22.87万 - 项目类别:
The control of allergic immune responses by follicular regulatory T cells
滤泡调节性 T 细胞对过敏性免疫反应的控制
- 批准号:
10165474 - 财政年份:2017
- 资助金额:
$ 22.87万 - 项目类别:
The Role of Follicular Helper T Cells in HIV Prime Boost Vaccination
滤泡辅助 T 细胞在 HIV 加强疫苗接种中的作用
- 批准号:
8875819 - 财政年份:2014
- 资助金额:
$ 22.87万 - 项目类别:
Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
- 批准号:
8853812 - 财政年份:2014
- 资助金额:
$ 22.87万 - 项目类别:
Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
- 批准号:
8681872 - 财政年份:2014
- 资助金额:
$ 22.87万 - 项目类别:
Control of airway inflammation and Th2 differentiation by microRNA 21
microRNA 控制气道炎症和 Th2 分化 21
- 批准号:
8434965 - 财政年份:2012
- 资助金额:
$ 22.87万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8289751 - 财政年份:2012
- 资助金额:
$ 22.87万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8522152 - 财政年份:2012
- 资助金额:
$ 22.87万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
用于完整表征抗体库的软件:从种系和 mRNA 序列组装到其蛋白质结构和靶标的深度学习预测
- 批准号:
10699546 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Anti-medin immunotherapy for vascular aging and related dementias
针对血管老化和相关痴呆的抗 Medin 免疫疗法
- 批准号:
10724869 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
HIPK1: a new immunomodulatory target for SLE
HIPK1:SLE 的新免疫调节靶点
- 批准号:
10647292 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别: